SCHEMBL1662883

SCHEMBL1662883

Cn1ccc(N)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1353327 0.97
Iodide SCHEMBL27502072 0.97
Ethoxycarbonyl Group SCHEMBL27604066 0.77 CA12 (0.32)
SCHEMBL17678036 0.72 ALDH1A1 (0.50)
SCHEMBL17233960 0.70
SCHEMBL12447216 0.69
SCHEMBL9809742 0.67 INMT (0.41)
SCHEMBL12020327 0.65
SCHEMBL19580288 0.65
SCHEMBL3078481 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024106781-A1 LIPID COMPOUND AND COMPOSITION FOR DELIVERY OF ACTIVE SUBSTANCE 한국생명공학연구원 2024-05-23 WO claimed
US-8486896-B2 Lipid tripeptide-based hydrogelator and hydrogel NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-07-16 US claimed
EP-2180027-B1 NOVEL LIPID-TRIPEPTIDE BASED HYDROGEL-FORMING AGENT AND HYDROGEL NISSAN CHEMICAL IND LTD (JP) 2011-10-26 EP claimed
US-20100279955-A1 NOVEL LIPID TRIPEPTIDE-BASED HYDROGELATOR AND HYDROGEL NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-11-04 US claimed
EP-2180027-A1 NOVEL LIPID-TRIPEPTIDE BASED HYDROGEL-FORMING AGENT AND HYDROGEL Nissan Chemical Industries, Ltd. (JP) 2010-04-28 EP claimed
US-12459925-B2 Sulphonyl urea derivatives as NLRP3 inflammasome modulators NodThera Limited (GB) 2025-11-04 US disclosed
EP-3728238-B1 SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS NODTHERA LTD (GB) 2025-06-18 EP disclosed
US-20240368129-A1 SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS NodThera Limited (GB) 2024-11-07 US disclosed
US-12025909-B2 Photoresponsive compound Konica Minolta, Inc. (JP) 2024-07-02 US disclosed
US-12012397-B2 Sulphonyl urea derivatives as NLRP3 inflammasome modulators NodThera Limited (GB) 2024-06-18 US disclosed
US-12006292-B2 Photoresponsive compound Konica Minolta, Inc. (JP) 2024-06-11 US disclosed
US-11994827-B2 Photoresponsive polymer Konica Minolta, Inc. (JP) 2024-05-28 US disclosed
EP-2180027-A1 NOVEL LIPID-TRIPEPTIDE BASED HYDROGEL-FORMING AGENT AND HYDROGEL Nissan Chemical Industries, Ltd. (JP) 2010-04-28 EP disclosed
US-20100048567-A1 Inhibitors of syk and JAK protein kinases PORTOLA PHARMACEUTICALS INC. (US) 2010-02-25 US disclosed
US-20100048567-A1 Inhibitors of syk and JAK protein kinases PORTOLA PHARMACEUTICALS INC. (US) 2010-02-25 US disclosed
CN-101605837-A Thermosetting composition HUNTSMAN ADV MAT SWITZERLAND (CH) 2009-12-16 CN disclosed
WO-2009136995-A2 INHIBITORS OF SYK PROTEIN KINASE PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-12 WO disclosed
CN-101370765-A Method for selectively producing primary amine SUMITOMO CHEMICAL CO (JP) 2009-02-18 CN disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed
WO-2007084786-A1 PYRIMIDINE DERIVATIVES USED AS PI-3 KINASE INHIBITORS NOVARTIS AG (CH) 2007-07-26 WO disclosed